CLBT on Nasdaq
Cellebrite DI Ltd.
Cellebrite DI Ltd. is a prepackaged software services company, listed on Nasdaq (CLBT).1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Xunlei Limited, PagerDuty or Sprout Social, Inc., or pick any stock.
- TickerCLBT on Nasdaq1
- IndustryServices-Prepackaged Software1
- Business address94 Shlomo Shmelzer Road, Petah Tikva, L3 49706022
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
We were incorporated on April 13, 1999 as a private limited liability company under the laws of the State of Israel. We are registered under the Israeli Companies Law as Cellebrite DI Ltd., and our registration number with the Israeli Registrar of Companies is 51-276657-7.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
84.2%Gross margin4
14.0%Operating margin4
16.5%Net margin4
18.6%Revenue growth, 20254
16.2%Return on equity4
$160.3MFree cash flow4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Subscription Services brought in 70% of the revenue Cellebrite DI Ltd. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Subscription Services | $209.8M | $271.0M | $330.8M |
| Term-Licenses | $70.7M | $82.0M | $96.2M |
| Professional Services | $31.1M | $30.9M | $30.9M |
| Other non-recurring | $13.6M | $17.3M | $17.8M |
Regions
Americas brought in 54% of the revenue Cellebrite DI Ltd. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | $172.2M | $215.5M | $256.6M |
| EMEA | $112.2M | $134.9M | $161.4M |
| Asia Pacific | $40.7M | $50.8M | $57.7M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue16¢$75.2M
- Research and development24¢$113.9M
- Other costs41¢$195.9M
- Income tax3¢$12.4M
- Profit16¢$78.3M
Out of $475.7M in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending8¢$13.2M
- Kept or used elsewhere92¢$160.3M
Out of $173.5M of cash from operations.4
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $475.7M | $401.2M | $325.1M |
| Cost of Revenue | $75.2M | $62.6M | $53.2M |
| Gross Profit, Total | $400.5M | $338.6M | $271.9M |
| Research and Development Expense | $113.9M | $98.4M | $84.4M |
| Selling and Marketing Expense | $154.8M | $132.4M | $110.8M |
| General and Administrative Expense | $65.3M | $50.9M | $43.4M |
| Operating Expenses, Total | $334.0M | $281.7M | $238.6M |
| Operating Income (Loss), Total | $66.5M | $56.9M | $33.2M |
| Nonoperating Income (Expense) | $24.2M | -$332.9M | -$108.8M |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | $90.7M | -$276.0M | -$75.6M |
| Income Tax Expense (Benefit) | $12.4M | $7.0M | $5.5M |
| Net Income (Loss) | $78.3M | -$283.0M | -$81.1M |
| Basic net income (loss) per share attributable to ordinary shareholders | $77.8M | -$283.0M | -$81.1M |
| Basic net income (loss) per ordinary share (in USD per share) | $0.32 | -$1.35 | -$0.43 |
| Diluted net income (loss) per share (in USD per share) | $0.31 | -$1.35 | -$0.43 |
| Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) | 241.6M shares | 209.5M shares | 190.2M shares |
| Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) | 249.9M shares | 209.5M shares | 190.2M shares |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $124.5M | $191.7M | ||
| Short-term deposits | $161.0M | $153.7M | ||
| Marketable securities | $151.5M | $101.8M | ||
| Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively) | $105.0M | $82.4M | ||
| Prepaid expenses and other current assets | $19.6M | $23.2M | ||
| Contract acquisition costs | $6.6M | $5.8M | ||
| Inventories | $7.6M | $8.9M | ||
| Total current assets | $575.9M | $567.6M | ||
| Other non-current assets | $14.6M | $7.7M | ||
| Marketable securities | $98.0M | $36.6M | ||
| Deferred tax assets, net | $10.9M | $11.1M | ||
| Property and equipment, net | $22.2M | $17.0M | ||
| Operating Lease, Right-of-Use Asset | $16.3M | $10.6M | ||
| Intangible assets, net | $81.5M | $11.3M | ||
| Goodwill | $119.6M | $28.7M | ||
| Total non-current assets | $363.0M | $123.0M | ||
| Total assets | $938.9M | $690.6M | ||
| Trade payables | $16.8M | $11.1M | ||
| Deferred revenues | $277.6M | $217.0M | ||
| Other accounts payable and accrued expenses | $71.2M | $63.3M | ||
| Operating lease liabilities | $4.0M | $4.1M | ||
| Total current liabilities | $369.7M | $295.5M | ||
| Other long-term liabilities | $16.7M | $7.0M | ||
| Operating lease liabilities | $18.7M | $6.8M | ||
| Deferred revenues | $49.5M | $45.2M | ||
| Total long-term liabilities | $84.9M | $59.0M | ||
| Total liabilities | $454.5M | $354.5M | ||
| Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $568.7M | $498.9M | ||
| Common stock par value per share (in NIS per share) | 0.00 ILS | 0.00 ILS | ||
| Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares | -$85.0K | -$85.0K | ||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2.2M | $2.1M | ||
| Accumulated deficit | -$86.5M | -$164.9M | ||
| Total Shareholders equity | $484.3M | $336.0M | $34.2M | $73.9M |
| Total liabilities and shareholders equity | $938.9M | $690.6M | ||
| Trade receivable, allowance for credit loss | $506.0K | $594.0K | ||
| Common stock, shares authorized (in shares) | 3.5B shares | 3.5B shares | ||
| Common Stock, Shares, Issued | 248.6M shares | 234.6M shares | ||
| Common stock shares outstanding (in shares) | 248.6M shares | 234.5M shares | ||
| Treasury Stock, Common, Shares | 41.8K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $124.5M | $191.7M | ||
| Short-term deposits | $161.0M | $153.7M | ||
| Marketable securities | $151.5M | $101.8M | ||
| Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively) | $105.0M | $82.4M | ||
| Prepaid expenses and other current assets | $19.6M | $23.2M | ||
| Contract acquisition costs | $6.6M | $5.8M | ||
| Inventories | $7.6M | $8.9M | ||
| Total current assets | $575.9M | $567.6M | ||
| Other non-current assets | $14.6M | $7.7M | ||
| Marketable securities | $98.0M | $36.6M | ||
| Deferred tax assets, net | $10.9M | $11.1M | ||
| Property and equipment, net | $22.2M | $17.0M | ||
| Operating Lease, Right-of-Use Asset | $16.3M | $10.6M | ||
| Intangible assets, net | $81.5M | $11.3M | ||
| Goodwill | $119.6M | $28.7M | ||
| Total non-current assets | $363.0M | $123.0M | ||
| Total assets | $938.9M | $690.6M | ||
| Trade payables | $16.8M | $11.1M | ||
| Deferred revenues | $277.6M | $217.0M | ||
| Other accounts payable and accrued expenses | $71.2M | $63.3M | ||
| Operating lease liabilities | $4.0M | $4.1M | ||
| Total current liabilities | $369.7M | $295.5M | ||
| Other long-term liabilities | $16.7M | $7.0M | ||
| Operating lease liabilities | $18.7M | $6.8M | ||
| Deferred revenues | $49.5M | $45.2M | ||
| Total long-term liabilities | $84.9M | $59.0M | ||
| Total liabilities | $454.5M | $354.5M | ||
| Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively | $0 | $0 | ||
| Additional paid-in capital | $568.7M | $498.9M | ||
| Common stock par value per share (in NIS per share) | 0.00 ILS | 0.00 ILS | ||
| Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares | -$85.0K | -$85.0K | ||
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2.2M | $2.1M | ||
| Accumulated deficit | -$86.5M | -$164.9M | ||
| Total Shareholders equity | $484.3M | $336.0M | $34.2M | $73.9M |
| Total liabilities and shareholders equity | $938.9M | $690.6M | ||
| Trade receivable, allowance for credit loss | $506.0K | $594.0K | ||
| Common stock, shares authorized (in shares) | 3.5B shares | 3.5B shares | ||
| Common Stock, Shares, Issued | 248.6M shares | 234.6M shares | ||
| Common stock shares outstanding (in shares) | 248.6M shares | 234.5M shares | ||
| Treasury Stock, Common, Shares | 41.8K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income (Loss) | $78.3M | -$283.0M | -$81.1M |
| Share-based compensation | $44.9M | $30.6M | $19.0M |
| Amortization of premium, discount and accrued interest on marketable securities | -$2.4M | -$2.9M | -$1.1M |
| Depreciation and amortization | $11.9M | $10.6M | $10.0M |
| Disposal and write-off of property and equipment | $554.0K | $0 | $0 |
| Abandonment of right-of-use assets and disposal of leasehold improvements | $1.8M | $0 | $0 |
| Interest on deposits and investments | -$8.2M | -$10.7M | -$7.7M |
| Deferred tax assets, net | $75.0K | -$4.0M | $5.1M |
| Remeasurement of Warrant liability | $0 | $110.7M | $34.1M |
| Remeasurement of Restricted Sponsor Shares liability | $0 | $65.9M | $29.7M |
| Remeasurement of Price Adjustment Shares liability | $0 | $173.1M | $55.5M |
| (Increase) decrease in trade receivables | -$15.8M | -$5.8M | $2.3M |
| Increase in deferred revenues | $49.8M | $22.3M | $46.1M |
| Increase in other non-current assets | -$6.9M | -$341.0K | -$5.6M |
| Decrease (increase) in prepaid expenses and other current assets | $5.6M | $3.2M | -$9.2M |
| Changes in operating lease right-of-use assets | $4.6M | $5.3M | $4.4M |
| Changes in operating lease liabilities | $547.0K | -$4.8M | -$4.2M |
| Decrease in inventories | $1.6M | $982.0K | $243.0K |
| Increase in trade payables | $4.9M | $2.8M | $3.7M |
| Increase in other accounts payable and accrued expenses | $4.2M | $17.6M | $734.0K |
| (Decrease) increase in other long-term liabilities | -$2.0M | $880.0K | $121.0K |
| Net Cash Provided by (Used in) Operating Activities, Total | $173.5M | $132.2M | $102.1M |
| Payments to Acquire Property, Plant, and Equipment | -$13.2M | -$8.6M | -$5.2M |
| Payments to Acquire Businesses, Net of Cash Acquired | -$147.5M | -$2.7M | $0 |
| Payments to Acquire Intangible Assets | $0 | -$2.0M | -$2.7M |
| Payments to Acquire Marketable Securities | -$321.2M | -$127.8M | -$55.3M |
| Proceeds from maturity of marketable securities | $153.0M | $60.0M | $56.3M |
| Proceeds from sales of marketable securities | $59.8M | $0 | $0 |
| Payments to Acquire Short-Term Investments | -$187.0M | -$207.0M | -$89.0M |
| Proceeds from Sale of Short-Term Investments | $187.9M | $138.7M | $73.4M |
| Net Cash Provided by (Used in) Investing Activities, Total | -$268.2M | -$149.5M | -$22.5M |
| Exercise of options | $20.1M | $17.3M | $19.1M |
| Proceeds from Employee Share Purchase Plan | $5.0M | $3.3M | $2.6M |
| Exercise of public warrants | $0 | $53.0K | $0 |
| Redemption of public warrants | $0 | -$11.0K | $0 |
| Net cash provided by financing activities | $25.1M | $20.7M | $21.8M |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total | -$69.7M | $3.3M | $101.3M |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | $2.5M | -$1.2M | $589.0K |
| Income Taxes Paid, Net | -$549.0K | $7.7M | $10.0M |
| Operating lease liabilities arising from obtaining right of use assets | $11.2M | $1.9M | $4.4M |
| Reclass and release of Restricted Sponsor Share | $0 | $113.1M | $0 |
| Reclassification and issuance of Price Adjustment Share | $0 | $254.8M | $0 |
| Reclassification and issuance of Price Adjustment Share | $0 | $164.8M | $0 |
| Unrealized gain (loss) on marketable securities, tax | $35.0K | $33.0K | $2.0K |
| Unrealized gain (loss) on hedging transactions, tax | $152.0K | $66.0K | $171.0K |
| Change in foreign currency translation adjustment | -$1.3M | $1.4M | -$1.0M |
No quarter-by-quarter statement was filed.
Corporate structure
Cellebrite DI Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Cellebrite DI Ltd.
- Pertento Partners LLP Filed SCHEDULE 13G on Cellebrite DI Ltd., latest Oct 9, 2026
- Voss Capital, LP Filed SCHEDULE 13G on Cellebrite DI Ltd., latest Aug 18, 2026
- Suncorporation Filed SCHEDULE 13G/A on Cellebrite DI Ltd., latest Feb 24, 2026 (5 filings since Feb 10, 2022)
- FMR LLC Filed SCHEDULE 13G/A on Cellebrite DI Ltd., latest May 12, 2025 (2 filings since Feb 12, 2025)
- TWC Tech Holdings II, LLC Filed SCHEDULE 13D/A on Cellebrite DI Ltd., latest Mar 20, 2025 (3 filings since Aug 29, 2024)
- IGP SAFERWORLD, LIMITED PARTNERSHIP Filed SCHEDULE 13G/A on Cellebrite DI Ltd., latest Feb 11, 2025 (4 filings since Feb 24, 2022)
- Weiss Asset Management LP Filed SC 13G/A on Cellebrite DI Ltd., latest Feb 7, 2022
- Cellebrite DI Ltd.
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Cellebrite DI Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $67.0M4 Dec 31, 2025 | $57.0M4 Dec 31, 2024 | +17.4% |
| Accumulated depreciation | $44.8M4 Dec 31, 2025 | $40.0M4 Dec 31, 2024 | +11.8% |
| Property and equipment, net | $22.2M4 Dec 31, 2025 | $17.0M4 Dec 31, 2024 | +30.7% |
| Operating-lease assets (leased space) | $16.3M4 Dec 31, 2025 | $10.6M4 Dec 31, 2024 | +53.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $124.5M4 Dec 31, 2025 | $191.7M4 Dec 31, 2024 | −35.1% |
| Marketable securities, current | $151.5M4 Dec 31, 2025 | $101.8M4 Dec 31, 2024 | +48.8% |
| Marketable securities, non-current | $98.0M4 Dec 31, 2025 | $36.6M4 Dec 31, 2024 | +167.6% |
| Debt securities available for sale | $249.5M4 Dec 31, 2025 | $138.4M4 Dec 31, 2024 | +80.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $119.6M4 Dec 31, 2025 | $28.7M4 Dec 31, 2024 | +316.4% |
| Intangible assets, net (excluding goodwill) | $81.5M4 Dec 31, 2025 | $11.3M4 Dec 31, 2024 | +620.6% |
| Finite-lived intangibles, gross | $95.2M4 Dec 31, 2025 | $24.1M4 Dec 31, 2024 | +295.4% |
| Accumulated amortization | $13.8M4 Dec 31, 2025 | $12.8M4 Dec 31, 2024 | +7.8% |
| Finite-lived intangibles, net | $81.5M4 Dec 31, 2025 | $11.3M4 Dec 31, 2024 | +620.6% |
Inventory
Leadership
Who has led Cellebrite DI Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerShiven Ramji Sep 25, 2026 to now9
- PresidentShiven Ramji May 7, 2026 to now10
- Chief financial officerDavid Barter Jul 9, 2026 to now11
Board members and other officers (16)
- Chief Technology OfficerChristopher Michael Wade Mar 18, 2026 to now12
- OfficerDavid Barter Mar 18, 2026 to now13
- OfficerHolly B. Windham Mar 18, 2026 to now14
- Global Chief Revenue OfficerMarcus Jewell Mar 18, 2026 to now15
- OfficerRonnen Armon Mar 18, 2026 to now16
- Chief Information OfficerSigalit Shavit Mar 18, 2026 to now17
- Chief People OfficerZohar Tadmor-Eilat Mar 18, 2026 to now18
- Board memberAdam Clammer Mar 18, 2026 to now19
- Board memberBuren Brandon Van Mar 18, 2026 to now20
- Board memberDafna Gruber Mar 18, 2026 to now21
- Board memberMichael David Capellas Mar 18, 2026 to now22
- Board memberNadine Baudot-Trajtenberg Mar 18, 2026 to now23
- Board memberRyusuke Utsumi Mar 18, 2026 to now24
- Board memberTroy Richardson Mar 18, 2026 to now25
- Board memberYonatan Domnitz Mar 18, 2026 to now26
- Board memberShiven Ramji Sep 25, 2026 to now9
Timeline
- Sep 25, 2026New chief executive Shiven Ramji becomes CEO9
Calendar
Coming up
- Nov 11, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.08 a share, on Nov 12, 2025.27
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
319 filings to the SEC since October 2021: 7 annual reports, 40 insider forms, 17 large holders, 255 other. The latest 20:
- Oct 9, 2026SCHEDULE 13G EDGAR
- Oct 7, 2026144 EDGAR
- Sep 29, 20264 PRIMARY DOCUMENT EDGAR
- Sep 29, 20264 PRIMARY DOCUMENT EDGAR
- Sep 28, 20264 EDGAR
- Sep 25, 20264 EDGAR
- Sep 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 17, 20264 EDGAR
- Sep 2, 20266-K CURRENT REPORT EDGAR
- Aug 27, 20264 EDGAR
- Aug 25, 20264 EDGAR
- Aug 24, 2026144 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 2026144 EDGAR
- Aug 19, 2026144 EDGAR
- Aug 19, 2026144 EDGAR
The 319 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 0 buys and 13 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Hogan Thomas E. | Sale | 25,299 | $11.29 | $285.6K | Form 4 |
| Aug 24, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 4,323 | $11.36 | $49.1K | Form 4 |
| Aug 21, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 12,562 | $11.24 | $141.2K | Form 4 |
| Aug 21, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 2,198 | $11.24 | $24.7K | Form 4 |
| Aug 12, 2026 | Hogan Thomas E. | Sale | 139,713 | $15.39 | $2.2M | Form 4 |
| Aug 12, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 411 | $16.07 | $6.6K | Form 4 |
| Aug 12, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 230 | $16.07 | $3.7K | Form 4 |
| Jul 8, 2026 | Barter DavidChief Financial Officer | Sale | 41,734 | $16.38 | $683.6K | Form 4 |
| Jul 2, 2026 | Hogan Thomas E. | Sale | 103,188 | $15.76 | $1.6M | Form 4 |
| May 21, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 5,673 | $13.13 | $74.5K | Form 4 |
| May 18, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 12,658 | $12.77 | $161.6K | Form 4 |
| May 12, 2026 | GEE DAVID NICHOLASChief Marketing Officer | Sale | 228 | $13.01 | $3.0K | Form 4 |
| May 12, 2026 | Jewell MarcusGlobal Chief Revenue Officer | Sale | 383 | $13.01 | $5.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Pertento Partners LLPSCHEDULE 13G, 1 filing Oct 9, 202628
- Voss Capital, LPSCHEDULE 13G, 1 filing Aug 18, 202629
- SuncorporationSCHEDULE 13G/A, 5 filings Feb 10, 2022 to Feb 24, 202630
- FMR LLCSCHEDULE 13G/A, 2 filings Feb 12, 2025 to May 12, 202531
- TWC Tech Holdings II, LLCSCHEDULE 13D/A, 3 filings Aug 29, 2024 to Mar 20, 202532
- IGP SAFERWORLD, LIMITED PARTNERSHIPSCHEDULE 13G/A, 4 filings Feb 24, 2022 to Feb 11, 202533
- Weiss Asset Management LPSC 13G/A, 1 filing Feb 7, 202234
SEC filer profile
How Cellebrite DI Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCellebrite DI Ltd.1
- CIK0001854587
- Filer statusLarge accelerated filer not an emerging growth company; not a shell company3
- Incorporated inIsrael3
- Fiscal year endsDecember 311
- Industry code (SIC)7372 Services-Prepackaged Software1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address94 Shlomo Shmelzer Road, Petah Tikva, L3 49706021
- Phone972 (73) 394-80001
- Shares outstanding249,439,817 shares as of Feb 23, 20263
- AuditorKOST FORER GABBAY & KASIERER, Tel-Aviv, Israel PCAOB ID 1281; it also attests to the company’s internal control over financial reporting3
- On EDGAR sinceApr 9, 20211
- Filings357 in all: 144 (176), 6-K (60), 4 (22), 425 (21), 3 (18), 424B3 (9), 20-F (5), SC 13G/A (5)1
All 28 form types
CORRESP (4), EFFECT (4), SCHEDULE 13G/A (4), F-4/A (3), S-8 (3), SCHEDULE 13G (3), UPLOAD (3), 20-F/A (2), POS AM (2), SC 13D/A (2), SC 13G (2), 144/A (1), 20FR12B (1), 25-NSE (1), 8-A12B (1), CERT (1), F-1 (1), F-4 (1), SC 13D (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (20-F) Mar 3, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Ordinary shares, par value NIS 0.00001 | CLBT | Nasdaq Global Market |
From the cover page of the 20-F filed Mar 3, 2026 (Section 12(b) of the Exchange Act).3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARShiven Ramji, President
- 11
- 12
- 13SEC EDGARDavid Barter, Officer
- 14SEC EDGARHolly B. Windham, Officer
- 15
- 16SEC EDGARRonnen Armon, Officer
- 17
- 18
- 19SEC EDGARAdam Clammer, Board member
- 20SEC EDGARBuren Brandon Van, Board member
- 21SEC EDGARDafna Gruber, Board member
- 22SEC EDGARMichael David Capellas, Board member
- 23
- 24SEC EDGARRyusuke Utsumi, Board member
- 25SEC EDGARTroy Richardson, Board member
- 26SEC EDGARYonatan Domnitz, Board member
- 27NasdaqNasdaq calendar
- 28
- 29
- 30
- 31
- 32
- 33
- 34